Two reasons for Delayed Release dosage forms are to protect the ________ and the _______. A. Drug and the patient’s liver B. Stomach and the intestines C. Drug and the manufacturer D. Stomach and the medicinal product

Which of the following are advantages of suppositories and inserts as dosage forms? Select all that apply. A. large doses or irritating drugs can be given by suppository B. a suppository is such a dignified way to administer a drug C. a suppository avoids first pass effect and gastrointestinal degradation of the drug D. suppositories can be expelled by defecation E. commercially prepared suppositories are available in fewer dose levels F. administration of unpleasant tasting/smelling drugs is possible, especially for children

Suggest 2 reasons why some medicines must be taken with or after food.

The most important parameter for extended release or delayed release products for which the USP (United States Pharmacopeia) standard requires testing is the dissolution profile. Here are the steps to understand why: Extended release or delayed release products are designed to release the active pharmaceutical ingredient (API) over a prolonged period of time. This is to maintain a constant drug concentration in the body, thereby improving the efficacy of the drug and reducing side effects. To ensure that these products are releasing the API as intended, it is crucial to test their dissolution profile. The dissolution profile refers to the rate and extent to which the API is dissolved from the dosage form and becomes available for absorption in the body. The USP has set standards for dissolution testing to ensure that the products are safe and effective. These standards specify the conditions under which the test should be conducted, including the type of dissolution apparatus to be used, the rotation speed, the dissolution medium, and the duration of the test. If a product does not meet the USP standards for dissolution, it may not release the API at the correct rate or to the correct extent, which could affect its therapeutic effect. Therefore, the dissolution profile is the most important parameter for extended release or delayed release products for which the USP standard requires testing. give a two sentence answer.

What are the two general situations that would alter the quality or performance of a solid dosage form and would also require FDA approval?

Match the term to the correct description or definition: Dosage form characterized by release of initial dose of drug followed by a second dose four to six hours later.